Join us
Find out about GHTC’s membership options and the benefits of becoming a member.
CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) is a global nonprofit partnership dedicated to supporting early-stage antibacterial research and development to address the rising threat of drug-resistant bacteria. CARB-X supports innovative therapeutics, preventatives, and rapid diagnostics. CARB-X is led by Boston University and funded by a consortium of governments and foundations.
Visit https://carb-x.org/Our members
We bring together nonprofits, academic institutions, and aligned businesses that are committed to advancing health equity through innovation.
